Centene stock is trading -21.49% below its average target price of $34.56 after marking a 3.7% during today's morning session. Analysts are giving the Large-Cap Medical Specialities company an average rating of hold and target prices ranging from $24.0 to $70.0 per share.
Centene has an average level of shares sold short, at 6.5% of its total share float. The stock's short ratio (also called days to cover) is 1.1. The company's insiders own 0.46% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Institutional investors own 101.6% of Centene's shares, which indicates they have a high level of confidence in the company.
Institutions Invested in Centene
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-06-30 | Vanguard Group Inc | 12% | 58,396,605 | $1,584,591,890 |
| 2025-06-30 | Blackrock Inc. | 9% | 45,213,772 | $1,226,875,713 |
| 2025-03-31 | FMR, LLC | 5% | 26,627,525 | $722,537,896 |
| 2024-12-31 | NORGES BANK | 5% | 25,357,664 | $688,080,218 |
| 2025-03-31 | State Street Corporation | 5% | 22,672,327 | $615,213,598 |
| 2025-03-31 | Harris Associates L.P. | 4% | 21,135,939 | $573,523,709 |
| 2025-03-31 | Capital World Investors | 3% | 14,909,941 | $404,581,252 |
| 2025-06-30 | Geode Capital Management, LLC | 3% | 13,208,639 | $358,416,422 |
| 2025-03-31 | Invesco Ltd. | 2% | 11,091,964 | $300,980,445 |
| 2025-03-31 | AQR Capital Management, LLC | 2% | 11,049,494 | $299,828,022 |
